A randomized study of beef lung and pork mucosal heparin in cardiac surgery.

[1]  G. S. Campbell,et al.  Activated clotting time monitoring of intraoperative heparinization: our experience and comparison of two techniques. , 1981, Surgery.

[2]  J. Baguet,et al.  In vivo release of a heparin-like factor in dogs during profound hypothermia. , 1981, The Journal of thoracic and cardiovascular surgery.

[3]  A. Montoya,et al.  Management of postoperative heparin rebound following cardiopulmonary bypass. , 1981, The Journal of thoracic and cardiovascular surgery.

[4]  A. Schwartz,et al.  Monitoring heparin anticoagulation and its neutralization. , 1981, The Annals of thoracic surgery.

[5]  F. Spencer,et al.  Lack of correlation between activated clotting time and plasma heparin during cardiopulmonary bypass. , 1981, Annals of surgery.

[6]  W. Bell,et al.  Heparin-associated thrombocytopenia: a comparison of three heparin preparations. , 1980, The New England journal of medicine.

[7]  B. Thompson,et al.  Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery. , 1979, American journal of surgery.

[8]  B. Thompson,et al.  Identification of heparin resistance during cardiac and vascular surgery. , 1979, Archives of surgery.

[9]  G. Barlow,et al.  Differential activities of heparins in human plasma and in sheep plasma. Effects of heparin molecular sizes and sources. , 1978, Thrombosis research.

[10]  Thomas Dp.  Heparin in the prophylaxis and treatment of venous thromboembolism. , 1978, Seminars in hematology.

[11]  T. Barrowcliffe,et al.  Anticoagulant activities of lung and mucous heparins. , 1978, Thrombosis research.

[12]  R. Bedford,et al.  Comparison of bovine lung and porcine intestinal heparin for arterial thrombosis in man. , 1977, American journal of hospital pharmacy.

[13]  J. Kaplan,et al.  Plasma Heparin Activity and Antagonism During Cardiopulmonary Bypass with Hypothermia , 1977, Anesthesia and analgesia.

[14]  W. Abbott,et al.  The relationship of heparin source to the incidence of delayed hemorrhage. , 1977, The Journal of surgical research.

[15]  Smith Tc,et al.  Equivalency of two lots of heparin and their effects on various coagulation tests. , 1976 .

[16]  B. Bull,et al.  Heparin therapy during extracorporeal circulation. II. The use of a dose-response curve to individualize heparin and protamine dosage. , 1975, The Journal of thoracic and cardiovascular surgery.

[17]  Adesh K. Jain,et al.  Anticoagulant potency of mucosal and lung heparin , 1975, Clinical pharmacology and therapeutics.

[18]  D. Bangham,et al.  Standards for heparin. , 1975, Advances in experimental medicine and biology.

[19]  N. Ellison,et al.  Heparin rebound. Studies in patients and volunteers. , 1974, The Journal of thoracic and cardiovascular surgery.

[20]  S. Diamond,et al.  Comparison of anticoagulant activity of two preparations of purified heparin , 1973, Clinical pharmacology and therapeutics.

[21]  F. Gómez-Pérez,et al.  Anticoagulant activity of two commercially available heparin preparations. A controlled study. , 1972, The Journal of clinical pharmacology and new drugs.

[22]  S. Chaithiraphan,et al.  Prevention of post-brachial-arteriotomy thrombosis. , 1972, Lancet.

[23]  P. L. Walton,et al.  Heterogeneity of Heparin , 1966, British journal of haematology.